Symptoms And Treatment Of Multiple Myeloma Symptoms

The most common symptoms are pale skin, fatigue, weight loss, fever, easy bruising, tiredness, shortness of breath, loss of appetite and constant nosebleeds. The mental symptoms are mixed emotions and denial (American Cancer Society). The environmental causes of Myelodysplastic syndrome is exposure to radiation and exposure to certain chemicals. This is called secondary Myelodysplastic syndrome. Natural causes of Myelodysplastic syndrome is family medical history and genetics. Men and woman have a higher risk of being diagnosed with Myelodysplastic syndrome if a family member had the disease (Elaine

Multiple myeloma (MM) is a rare life-threatening cancer that affects the white blood cells known as plasma cells that are found in the soft, spongy tissue at the center of the bones, called bone marrow. The plasma cells are useful in fighting infections by producing antibodies that recognize and attack germs. The plasma cells are transformed into malignant myeloma cells when there are high levels of M proteins or better known as the production of abnormal antibodies from a result of myeloma cells. These M proteins multiple and block out normally functioning antibodies and the end results are bone damage or kidney problems. An individual can have blood tests or urine tests done to determine if they have multiple myeloma. In the article, “The work of living with a rare cancer: multiple myeloma” the authors explain how this type of cancer still remains incurable, but treatable that patients can expect to live longer, approximately five to seven years than what two decades ago. This was not expected for patients diagnosed with multiple myeloma during the 1990s, since patients were expected to only live about two and a half years after being diagnosed. Treatment for multiple myeloma throughout the years has advanced greatly yet a cure is still to be discovered. This essay will focus of the causes, the sign and symptoms, how multiple myeloma is detected and diagnosed, and how multiple myeloma is treated.

Multiple myeloma, also known as myeloma, hematologic cancer, or cancer of the blood is a plasma cell cancer, a type of white blood cell made in the bone marrow that is responsible for creating antibodies. A Multiple myeloma diagnosis means a group of these plasma cells has become cancerous and is multiplying. This cancerous multiplication of plasma cells raises the the level of abnormal proteins in circulating blood, and reduces the space available in the bone marrow for making healthy plasma cells . Health problems caused by multiple myeloma can affect your bones, immune system, kidneys and red blood cell count. The lifetime risk of getting multiple myeloma is 1 in 149 (0.67%).

Multiple myelomas are formed when plasma cells begins to grow uncontrollably. Plasma cells release immunoglobulins (antibodies) that help the body fight against germs. The bone marrow is rich in plasma cells, and it is the perfect place for growth of new cells. When the plasma cells grow out of control, they form clusters known as a tumor. If just a single tumor is formed, it is called a solitary plasmacytoma, but if more than one tumor exists, it is known as multiple myeloma.

Multiple myeloma is a cancer of the plasma cells in the bone marrow. These cells typically contribute in the immune system, but in this cancer, they can accumulate and block healthy plasma cells. The cancer cells begin to divide until they spread into the bone marrow and eventually weaken the hard cortex of the bone outside of the marrow. The erosion of the bone marrow causes pain or even breaks and fractures of the bones damaged by the cancer. Multiple Myeloma is an individual type of cancer centered around the cancerous, plasma cells, and is categorized by its symptoms, development, and treatment.

They are known as T- Lymphocytes and B-Lymphocytes. B-cells are usually distinguished with humoral immunity because b-cells circulate freely through the lymph system. Whereas T-cells are distinguished by humoral immune response because they act with antigens within other cells. Once these lymphocyte have been produced with the help of bone marrow stromal cells (which are a type of stem cell that is present in red bone marrow) they are released into the blood stream where they travel up to the thymus, and other lymphoid organs. When B-cells, also known as memory cells, leave the bone marrow, they become activated (true b-cells) This process involves the addition of a membrane protein known as immunoglobin M. (IgM) This membrane protein acts a receptor for antigens. Therefore they can said to be the binding site for antibodies. Once an antigen attaches itself to IgM receptor, a signal transduction pathway occurs through tails that descend down into the cells cytoplasm causing them to release antibodies. The second cell type, T-cells, are produced in the bone marrow, through the the same way B-cells are produced. The only difference is they mature in the thymus. This occurs because they undergo genetic recombination of their alpha

Multiple Myeloma is a neoplastic disease that involves the plasma cells within bone marrow. Plasma cells are a type of white blood cell that helps make up our immune system. They work within our immune system by generating antibodies that guard us from microorganisms and other unsafe materials. Although multiple myeloma forms in the immune system, the abnormal antibodies decrease the effectiveness of the body ability to fight infection. Since multiple myeloma is an uncommon cancer, the etiology is idiopathic, unknown. When plasma cells start to divide rapidly they become abnormal, and this is when myeloma starts. Healthy patients have a 5%

Multiple myeloma is a form of cancer that results from the uncontrolled growth of abnormal plasma cells. Plasma cells are a type of white blood cell produced in the soft tissue inside bones (bone marrow). These are cells in your blood that normally help you fight infection. They are part of your body’s defense system (immune system). Plasma cells that become cancerous will grow out of control. As a result, they interfere with normal blood cells and many important functions that normal cells perform in the body. With multiple myeloma, the abnormal plasma cells cause multiple tumors to form.

What if patients that suffer from Multiple Myeloma could finally have a treatment opinion with the aid of the immunology hormone, Thymosin ß-4? This hematologic (blood) disease has no cure at this specific time, but there are some factors that increase the susceptibility of contracting this disease. The factors include being over the age of 65, hereditary disposition and race also, people that already suffer a blood disease will probably contract MM. Why is trying to treat MM so important? Multiple Myeloma is stated as a cancer that is formed in a specific type of white blood cell (plasma cells). The main role of plasma cells is to secrete antibody that recognizes and attacks germs. These malignant plasma cells result in an increase of immunoglobulin components, most commonly IgG. This up regulation of IgG can ultimately cause kidney problems. To fully understand how this hormone may help patients that suffer from this disease first, I want to look at how the immune system interacts with hormones. Then, discuss what Thymosin ß-4 is and the effects on the inhibition of MM.

At all stages of MM, from treatment, relapse, remission to refractory, patients will face a high burden of biopsychosocial impacts. MM is characterised by the formation of tumours as a result of the overproduction and accumulation of malignant plasma cells in the bone marrow and other surfaces of bones in various parts of the body (Barber & Mullen, 2017; Dowling, Kelly, & Meenaghan, 2016). Consequently, these tumours causes the inhibition of osteoblasts and elevation of osteoclasts (Silbermann & Roodman, 2013). Thence, it is evident that up to 90% of individuals with MM suffer from hypercalcaemia and increased bone resorption (Silbermann & Roodman).

At all stages of MM, from diagnosis, remission, relapse to refractory, patients will face a high burden of biopsychosocial impacts. MM is characterised by the formation of tumours as a result of the overproduction and accumulation of malignant plasma cells in the bone marrow and on surfaces of various bones the body (Barber & Mullen, 2017; Dowling, Kelly, & Meenaghan, 2016). Consequently, these tumours causes the inhibition of osteoblasts and elevation of osteoclasts (Silbermann & Roodman, 2013). Thence, it is evident that up to 90% of individuals with MM suffer from hypercalcaemia and increased bone resorption (Silbermann & Roodman).

Immunoglobulins that are vital to the host immunity are absorbed through specific receptors (called as Fc receptors)

Lymphocytes can be broken down into B and T cells. The B cells main role in the immune system is the production of the antibodies, which are the proteins that recognize the antigens and attach to them. Once the antigen and antibody are attached, the B cell will then mark

When an antigen is detected, several types of cells work together to recognize and respond to it. These cells trigger the B cells to produce antibodies. Antibodies and their responding antigens fit together like a key and a lock. Although antibodies can recognize an antigen and lock onto it, they are not capable of destroying it without help. That is the job of the specific T cells, also called “killer cells”. The T cells are part of the system that destroys antigens that have been tagged by antibodies or cells that have been infected or somehow changed. T cells are also involved in helping signal other cells of the immune system to do their jobs.

Another type of cells that protect your body is the Phagocytes. Phagocytes are types of white blood cells that directly ingest the harmful pathogens through the process of phagocytosis. They bind to the pathogen and engulf it. When it engulfs the pathogen, Phagocytes keep the antigen so it can be presented to cells to make antibodies. (Kidshealth.org)